| 229.44 6.45 (2.89%) | 09-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 283.12 |
1-year : | 330.68 |
| Resists | First : | 242.39 |
Second : | 283.12 |
| Pivot price | 229.3  |
|||
| Supports | First : | 225.52 |
Second : | 215.09 |
| MAs | MA(5) : | 222.04 |
MA(20) : | 229.06 |
| MA(100) : | 208.97 |
MA(250) : | 233.13 |
|
| MACD | MACD : | 1.2 |
Signal : | 2.9 |
| %K %D | K(14,3) : | 29.1 |
D(3) : | 19.2 |
| RSI | RSI(14): 56 |
|||
| 52-week | High : | 281.88 | Low : | 179.75 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ RMD ] has closed below upper band by 49.5%. Bollinger Bands are 9.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 234.73 - 235.85 | 235.85 - 236.87 |
| Low: | 223.04 - 224.34 | 224.34 - 225.52 |
| Close: | 227.31 - 229.44 | 229.44 - 231.37 |
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Tue, 15 Sep 2026
ResMed (NYSE:RMD) Trading 4.5% Higher - Here's What Happened - MarketBeat
Tue, 15 Sep 2026
ResMed (RMD) Stock Surges Following Upgraded Rating and Price Ta - GuruFocus
Tue, 15 Sep 2026
Resmed Inc Stock (RMD) Moved Up by 3.05% on Sep 15: A Full Analysis - TradingKey
Tue, 15 Sep 2026
Is This the Right Time to Retain Resmed Stock in Your Portfolio? - TradingView
Tue, 15 Sep 2026
ResMed stock upgraded at RBC Capital Markets (RMD:NYSE) - Seeking Alpha
Tue, 15 Sep 2026
ResMed Inc. $RMD Shares Sold by Corient Private Wealth LP - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 144 (M) |
| Shares Float | 143 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 71.4 (%) |
| Shares Short | 12,790 (K) |
| Shares Short P.Month | 13,540 (K) |
| EPS | 10.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 45.65 |
| Profit Margin | 26.9 % |
| Operating Margin | 30.8 % |
| Return on Assets (ttm) | 14 % |
| Return on Equity (ttm) | 24.2 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | 24.12 |
| Sales Per Share | 39.16 |
| EBITDA (p.s.) | 14.55 |
| Qtrly Earnings Growth | 2.4 % |
| Operating Cash Flow | 1,810 (M) |
| Levered Free Cash Flow | 939 (M) |
| PE Ratio | 21.97 |
| PEG Ratio | 1.3 |
| Price to Book value | 5.02 |
| Price to Sales | 5.85 |
| Price to Cash Flow | 18.28 |
| Dividend | 0.66 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|